Category: Diagnostics
Leading diagnostics information services provider, Quest Diagnostics, and South Carolina’s Regional Medical Center (RMC) have announced a partnership aimed at enhancing the value and quality of diagnostic services for doctors and their patients. Under the new partnership agreement, Quest would be providing full laboratory management services. Steve Rusckowski, President, Chairman …
The shift that will occur due to elimination of hospital fees for imaging services is anticipated to reduce patient costs by nearly $7 million a year. UNC REX Healthcare, the private, not-for-profit health care system, recently announced that it has joined forces with Wake Radiology to expand specialized imaging services …
Merck & Co. has recently announced that it has agreed to acquire Immune Design in a deal valued at approx. $300 million, for boosting Merck’s vaccine pipeline and technology capabilities. Apparently, Immune Design had reduced its workforce by 18% last year and established a new lead candidate, after its previous …
The study was aimed at developing and internally validating the PRODIGY score, which is an accurate OIRD risk assessment scoring tool. Medtronic plc, one of the largest medical technology, services and solutions companies in the world has recently announced that PRODIGY, a study to monitor people at risk of opioid-induced …
The company wants to establish a global leader in tumor precision medicine brand and also lead China’s cancer genetic testing industry. Chinese biotech company Burning Rock has reportedly completed a $125.5 million (850 million yuan) Series C funding round which was led by GIC, the sovereign wealth fund of Singapore. …
The deal is to be renewed every two years after its initial five-year term and will continue thus until cancelled. WuXi Biologics, a leader in biologics discovery, development and manufacturing offering open-access biologics technology recently announced that it has entered into an exclusive manufacturing partnership with Amicus Therapeutics, a biotechnology …
SQZ Biotechnologies, a cell therapy conglomerate renowned for developing novel treatments for a wide range of diseases, has recently announced the expansion of its collaboration with Roche in cellular therapy. As per trusted sources, the expanded partnership with Roche’s cancer immunotherapy expertise would further SQZ’s innovation synergistic combination as well …
Bristol-Myers Squibb (BMS) and Compugen, the Israeli genomics-based drug and diagnostic discovery company have made an announcement recently informing that the two companies have entered into a clinical trial partnership. The companies will undertake trial to evaluate COM701 from Compugen with Opdivo, BMS’s PD-1 immune checkpoint inhibitor, in patients having …
Pharmaceutical giant Eli Lilly and Co confirmed recently that the company’s new, two-in-one diabetes drug successfully lowered blood sugar and reduced weight in its trials. The announcement propelled Lilly’s shares to a record high whereas those of rival Novo Nordisk had dropped. Lilly’s innovative new drug is designed to target …